Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it has completed a clinical trial and 510(k) submission to the US Food and Drug Administration for its Bordetella Direct Test for Bordetella pertussis, the infectious agent that causes whooping cough. The company is also seeking a CE mark for the test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.